GlassScriptPhysician profile
Jessica L Young
NPI 1457617870
$212.10
in general payments reported to CMS, 2019-2025
7 companies · $18.49 in 2025
The $18.49 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $81.34 · 2022: $22.29 · 2023: $67.69 · 2024: $22.29 · 2025: $18.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $108.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.34 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $28.94 | 2023 | Camzyos |
| Alexion Pharmaceuticals, INC. | $22.29 | 2024 | Ultomiris |
| Bausch & Lomb Americas INC. | $22.29 | 2022 | |
| Janssen Biotech, INC. | $19.72 | 2023 | Darzalex |
| Paratek Pharmaceuticals, INC. | $19.03 | 2023 | Nuzyra |
| Stryker Corporation | $18.49 | 2025 | Sage Self Oral Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.